Short description
Xynomic Pharmaceuticals, Inc. is a clinical stage oncology-focused biopharmaceutical company.
Description
Xynomic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies.Xynomic Pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in China, US and rest of the world. Xynomic Pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Shanghai, Shanghai, China, Asia
Founded on
January 1, 2016
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccessforu, Noaccess, Uh Ohhhh, Absolutely Noaccess, Uh Ohhhh
Sign in for full access
Founders
Mark Xu